Vital Therapies may sell $30 million of stock through public offering

BofA Merrill Lynch helps fund clinical development of the ELAD System

By Devika Patel

Knoxville, Tenn., Oct. 22 – Vital Therapies, Inc. will price a $30 million public offering of common stock with a $4.5 million 30-day greenshoe, according to a Form S-1 filed Monday with the Securities and Exchange Commission.

BofA Merrill Lynch is the bookrunning manager.

Proceeds will be used for clinical development of the ELAD System, working capital and other general corporate purposes.

The biotherapeutic company is based in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.